Arrhythmia: therapies Drugs for irregular heart rhythms, and anticoagulation Flashcards
What is an arrhythmia
Deviation from the normal rhythm of the heart
Types of arrhythmias
Sinus
Tachycardia
Bradycardias
Tachycardias
Supraventricular (atrial fibillation and SVT (junctional) Ventricular arrhythmia (Tachycardia and fibrillation)
Resting Membrane Potential
- During RMP the inside of the cell is a net negative charge relative to the outside
- Dependent on the sodium-potassium ATPase pump (requires energy)
Action Potential (3)
- Na+ enters the cell causing depolarisation once the threshold hits -40 mV
- Ca++ enters the cell, initiation of contraction
- K+ exits the cell causing repolarisation
Vaughan-Williams Classification antiarrhythmics
Class I- V
Class IA electrophysiological property
(moderate) sodium-channel blockade, thus reducing amplitude of AP and conduction velocity
Class IA examples (3)
Quinidine
Procainamide
Dispyramide
Class IB electrophysiological property
(Weak) sodium-channel blockades, thus reducing amptitude of AP and conduction velocity
Class IB drugs examples (3)
Lidocaine
Mexeletine
Tocainide
Class IC electrophysiological properties
(strong) sodium-channel blockade thus reducing amplitude of AP and conduction velocity
Class IC drug examples
Flecainide
Propafenone
Class II electrophysiological properties
B-Adrenergic receptor antagonism
Class II examples
Atenolol
Bisoprolol
Class III electrophysiological peoperties
Prolong refractoriness (slow K flow out of cells)
Class III drug examples
Amiodorane
Bretylium
Sotalol
Class IV electrophysiological properties
Calcium channel blockade
Class IV drug examples
Diltiazem
Verapamil
Class V drug
Other
Digoxin
Class I drug most commonly used
Fleicanide
Action of Class II (2)
Prolongs phase 4 depolarisation (slows SA discharge and AV conduction and reduces excitability in non-nodal cardiac tissues)
Shortens phase 2- negative effect on contractility
First line for atrial fibrillation
Class II drugs
Class III drugs are used for
dysrhythmias that are difficult to treat
• Life-threatening ventricular tachycardia or fibrillation, atrial fibrillation or flutter- resistant to other drugs
Use of Amiodarone
VT and supraventricular tachycardia
Drug interactions of Amidodarone
Digoxin
Side effects of Amiodarine (5)
Thyroid (hypo or hyper) Pulmonary fibrosis Slate grey pigmentation Corneal deposits LFT abnormalities
Class IV (4)
- Calcium channel blockers- bind to Lcard- type voltage gated Ca++ channels
- Depress phase 4 depolarisation in SA and AV nodes
- Slow the HR (decrease automaticity and slows AV conduction)
- Shortens phase 2 plateau phase (reduce contractility)
Digoxin (class 5) properties
have properties of several classes and are not present in a particular class
Action of Digoxin (5)
- Cardiac glycoside
- Inhibits the sodium-potassium ATPase pump
- Increases vagal tone- slows SA/AV node conduction
- Complex effect on the cardiac action potential- reduces the refractory period in the myocardium
- Increases Ca++ intracellular- positive inotropic effect
Indications for Digoxin (2)
Atrial dysrhythmias
Heart failure
Digoxin Toxicity (6)
- Nausea and vomiting
- Xanthopia- objects appear yellow
- Bradycardia
- Tachycardia
- Arrhythmias: VT and VF
- Reverse tick appearance of ST segment in lateral leads
Digoxin Toxicity Treatment (3)
Stop digoxin
Give Digibind
More serious is potassium levels are low
Action of Adenosine
Slows/blocks conduction through AV node
Use of Adenosine
Used to convert paroxysmal supraventricular tachycardia to sinus rythm
Features of Adenosine (4)
Very short half life
Only administered as fast IV push
May cause asystole for a few seconds
Minimal side effects
All antiarrhythmics can cause___
arrhythmias
Indications for anticoagulation
Atrial fibrillation- risk of stroke and pulmonary embolism
Metallic heart valves
DVT/PE
Thrombosis in AF is caused when what 3 things are compromised
Stasis
Abnormal blood
Abnormal vessels
Characteristics of the ideal anti-coagulant (6)
- Oral
- No need for monitoring
- No interaction with food or drugs
- Given once or twice a day/fixed dose irrespective of body weight/age
- As effective as warfarin
- Safer than warfarin
Oral anticoagulants and their function (3)
- Warfarin- Vitamin K reductase antagonist- prevents the production if active clotting factors
- Dabigatran- Direct Thrombin Inhibitor
- Rivaroxaban, Apixaban, Edoxaban- Direct Xa inhibitors
Production of Clotting factors (5)
- Vitamin K epoxide reductase
- Reduced vitamin K
- Vitamin K epoxide
- Clotting factor precursors
- Complete clotting factors (II, VII, IX and X)
INR
Prothrombin Time
Time it takes for blood to clot
International normalised ratio
Normal INR
1
Therapeutic INR is normally
2.5-4.0
Adverse effects of Warfarin (6)
• Bleeding (dose related) • Interaction with multiple drugs • Pregnancy Teratogenic (chondrodysplasia) Retroplacental bleeding and foetal intracerebral bleeding Avoid in first and third trimester
What enzyme metabolises Warfarin and what are the consequences of this (4)
Cytochrome P450
Interacts with drugs such as macrolide AB
Antifungals
Antiepileptic drugs
Drugs that increase warfarin activity (5)
Aspirin Sulfonamides Cimetidine Erythromycin Antibiotics (oral)
How does Aspirin
Sulfonamides increase warfarin activity
Decrease binding of warfarin to albumin
How does Cimetidine
Erythromycin increase warfarin activity
Inhibit degradation of warfarin
How does Antibiotics (oral) increase warfarin activity
Decrease synthesis of clotting factors
Drugs that promote bleeding (2)
Aspirin
Heparin
How does aspirin promote bleeding
Inhibition of platelets
How does Heparin promote bleeding
Inhibition of clotting factors
Drugs that decrease Warfarin activity (4)
Barbiturates
Phenytoin
Vitamin K
Cholestyramine
How does Barbiturates and Phenytoin decrease warfarin activyt
Induction od metabolising enzyme cytochrome P450
How does Vitamin K decrease warfarin activity
Promote clotting factor synthesis
How does Cholestyramine decrease warfarin activity
Reduces absorption
Inhibitors of Cytochrome P450 (8) (increases effect of warfarin)
- Omeprazole
- Disulfiram
- Erythromycin
- Valproate
- Isoniazid
- Ciprofloxacin and Cimetidine
- Ethanol (acutely)
- Sulphonamides
Inducers of Cytochrome P450 (reduced effect of Warfarin)
- Alcohol (chronic use)
- Barbiturates
- Carbamazepine
- Phenytoin
- Rifampicin
- Sulphonylureas
Monitoring warfarin therapy (4)
- Regular INR
- Watch if therapy altered
- Patient education
- Alcohol intake